APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,563,634 | -45.4% | 41,105 | +30.7% | 0.01% | -40.9% |
| Q2 2023 | $2,866,006 | +20.7% | 31,460 | -12.6% | 0.02% | +10.0% |
| Q1 2023 | $2,374,033 | -5.9% | 35,992 | -26.3% | 0.02% | -9.1% |
| Q4 2022 | $2,523,810 | +4.0% | 48,807 | +37.4% | 0.02% | 0.0% |
| Q3 2022 | $2,426,000 | +28.8% | 35,519 | -14.8% | 0.02% | +46.7% |
| Q2 2022 | $1,884,000 | -14.0% | 41,678 | -3.3% | 0.02% | +15.4% |
| Q1 2022 | $2,190,000 | -4.0% | 43,099 | -10.7% | 0.01% | +8.3% |
| Q4 2021 | $2,281,000 | +58.5% | 48,251 | +10.6% | 0.01% | +33.3% |
| Q3 2021 | $1,439,000 | – | 43,644 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |